放射诱导应激颗粒阻隔RFX-1/RBM47抑制焦亡导致鼻咽癌放射抵抗的机制
批准号:
82073330
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
赵充
依托单位:
学科分类:
肿瘤治疗抵抗
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
赵充
中文摘要
放射抵抗是鼻咽癌治疗失败的主要原因,阐明其机制并鉴定关键靶点至关重要。前期我们首次发现GSDME依赖的焦亡是鼻咽癌细胞受照射后重要的死亡方式,其发生率与放射敏感性正相关;此外,射线可诱导鼻咽癌细胞产生由eIF2α磷酸化启动组装的应激颗粒,其数量与焦亡发生率负相关;且应激颗粒内含RFX-1和RBM47蛋白,敲减RFX-1或RBM47均下调GSDME mRNA和蛋白表达致放射抵抗;进一步发现RFX-1激活GSDME转录,RBM47结合并稳定GSDME mRNA。由此提出科学假说:射线诱导鼻咽癌细胞内ROS升高,使eIF2α磷酸化激活应激颗粒组装,在空间上阻隔RFX-1和RBM47从多层面下调GSDME表达,从而抑制焦亡导致鼻咽癌放射抵抗。本项目将明确应激颗粒及焦亡在鼻咽癌放射抵抗中的作用,阐明应激颗粒阻隔RFX-1和RBM47发挥功能、抑制焦亡致放射抵抗的机制,为逆转鼻咽癌放射抵抗提供新靶点。
英文摘要
Radiotherapy is the standard of care for nasopharyngeal carcinoma (NPC) and the radioresistance is the main cause for treatment failure, which shows significant importance to clarify its mechanism and identify the key targets. We firstly found that except apoptosis, GSDME-dependent pyroptosis occurred broadly among NPC cell lines after receiving radiation, which was positively correlated with radiosensitivity. Besides, we also found considerable stress granules (SGs) initiated by eIF2α phosphorylation in the NPC cell cytoplasm after radiation, which was negatively correlated with the GSDME-dependent pyroptosis. Further studies indicated that SGs sequestered RFX-1 and RBM47, and knocking down either of them could inhibit GSDME transcription and expression inducing radioresistance; More importantly, we found that the RFX-1 could activate GSDME transcription by binding to its promoter region, and the RBM47 could stabilize GSDME mRNA when binding together. Therefore, we put forward the following scientific hypothesis: radiation could increase ROS to induce eIF2α phosphorylation, then initiate the assembly of SGs, which down-regulate GSDME expression from different levels through sequestering RFX-1 and RBM47 in space, inhibiting the pyroptosis and leading to NPC radioresistance. This project will furtherly investigate the detailed mechanisms underlying how SGs sequester RFX-1 and RBM47 and what are the detailed binding sites of RFX-1 and RBM47 to GSDME, which probably supply novel biomarkers and targets for promoting NPC’s radiosensitivity.
放射抵抗是鼻咽癌复发转移的重要原因,本项目聚焦辐射诱导细胞焦亡以及应激颗粒组装,临床研究与实验研究相结合,深入探究了放射抵抗的分子机制及其关键调控因子,有望为肿瘤的临床诊治提供新的标志物和潜在的治疗靶点。项目取得的主要成果包括:1. RNA结合蛋白G3BP1在鼻咽癌中显著上调,与患者不良生存预后显著相关,通过一系列实验研究发现G3BP1可通过促进辐射诱导的应激颗粒组装,从而抑制辐射诱导的细胞凋亡促进鼻咽癌放射抵抗。 2.在进行关于GSDME蛋白相关实验研究时我们发现,SNRPD3在转录水平上通过调控GSDME pre-mRNA的可变剪接,抑制GSDME成熟mRNA和蛋白质的生成,这一过程显著抑制了辐射诱导的GSDME介导的细胞焦亡,促进了NPC细胞放射抵抗;OTUD4则参与翻译后调控促进GSDME介导的细胞焦亡,OTUD4通过去泛素化增加GSDME蛋白稳定性,促进了GSDME依赖的细胞焦亡,最终提高了鼻咽癌细胞的放射敏感性(Journal of Experimental & Clinical Cancer Research,2022)。3. 功能性RNA调控鼻咽癌恶性进展的分子机制及临床相关性:通过临床收集到的鼻咽癌组织标本进行RNA-seq测序,结合一系列实验研究,我们发现LINC00173与细胞核中检查点激酶2(CHK2)结合,破坏辐照诱导的CHK2磷酸化,进而抑制P53信号通路的激活,抑制细胞凋亡,导致鼻咽癌细胞放射抵抗(Cancer Gene Ther,2023);胰岛素样生长因子2 mRNA结合蛋白(IGF2BP3)以m6A依赖性方式结合NOTCH3 mRNA,抑制CCR4-NOT复合物介导的去腺苷降解,以维持NOTCH3 mRNA的稳定性,从而激活NOTCH3信号通路,增加干性相关基因的转录,最终促进肿瘤转移(Oncogene,2023)。4. 鼻咽癌相关临床研究中,通过随访456例局晚期鼻咽癌患者,发现不同T和N分期的患者死亡风险差异显著,据此将患者分为高、中、低危,低风险患者接受顺铂为基础的同步放化疗即可很好控制肿瘤(Radiation oncology,2023)。项目已在《Oncogene》等期刊上发表5篇高影响力论文,且均为JCR一区期刊。研究为鼻咽癌的放射治疗、放射抵抗机制以及临床治疗策略的优化提供了潜在治疗靶点。
TFRC基因扩增诱导鼻咽癌放疗耐受导致肿瘤复发的分子机制
-
批准号:81872469
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:赵充
-
依托单位:
国内基金
海外基金